Literature DB >> 32038931

Molecular studies of lung neuroendocrine neoplasms uncover new concepts and entities.

Lynnette Fernandez-Cuesta1, Matthieu Foll1.   

Abstract

Entities:  

Year:  2019        PMID： 32038931      PMCID： PMC6987337          DOI： 10.21037/tlcr.2019.11.08

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  29 in total

1.  Data Sharing.

Authors:  Dan L Longo; Jeffrey M Drazen
Journal:  N Engl J Med       Date:  2016-01-21       Impact factor: 91.245

Review 2.  Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data.

Authors:  Charles M Rudin; John T Poirier; Lauren Averett Byers; Caroline Dive; Afshin Dowlati; Julie George; John V Heymach; Jane E Johnson; Jonathan M Lehman; David MacPherson; Pierre P Massion; John D Minna; Trudy G Oliver; Vito Quaranta; Julien Sage; Roman K Thomas; Christopher R Vakoc; Adi F Gazdar
Journal:  Nat Rev Cancer       Date:  2019-05       Impact factor: 60.716

3.  Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations.

Authors:  Michele Simbolo; Stefano Barbi; Matteo Fassan; Andrea Mafficini; Greta Ali; Caterina Vicentini; Nicola Sperandio; Vincenzo Corbo; Borislav Rusev; Luca Mastracci; Federica Grillo; Sara Pilotto; Giuseppe Pelosi; Serena Pelliccioni; Rita T Lawlor; Giampaolo Tortora; Gabriella Fontanini; Marco Volante; Aldo Scarpa; Emilio Bria
Journal:  J Thorac Oncol       Date:  2019-05-11       Impact factor: 15.609

Review 4.  Recent advances in the molecular landscape of lung neuroendocrine tumors.

Authors:  Giuseppe Pelosi; Fabrizio Bianchi; Paul Hofman; Linda Pattini; Philipp Ströbel; Fiorella Calabrese; Salma Naheed; Chloe Holden; Judith Cave; Hanibal Bohnenberger; Helen Dinter; Sergio Harari; Adriana Albini; Angelica Sonzogni; Mauro Papotti; Marco Volante; Christian H Ottensmeier
Journal:  Expert Rev Mol Diagn       Date:  2019-03-27       Impact factor: 5.225

5.  Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift.

Authors:  Alessandra Fabbri; Mara Cossa; Angelica Sonzogni; Paolo Bidoli; Stefania Canova; Diego Cortinovis; Maria Ida Abbate; Fiorella Calabrese; Nazarena Nannini; Francesca Lunardi; Giulio Rossi; Stefano La Rosa; Carlo Capella; Elena Tamborini; Federica Perrone; Adele Busico; Iolanda Capone; Barbara Valeri; Ugo Pastorino; Adriana Albini; Giuseppe Pelosi
Journal:  Virchows Arch       Date:  2017-04-27       Impact factor: 4.064

6.  Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm.

Authors:  Giuseppe Pelosi; Fabrizio Bianchi; Elisa Dama; Michele Simbolo; Andrea Mafficini; Angelica Sonzogni; Sara Pilotto; Sergio Harari; Mauro Papotti; Marco Volante; Gabriella Fontanini; Luca Mastracci; Adriana Albini; Emilio Bria; Fiorella Calabrese; Aldo Scarpa
Journal:  Virchows Arch       Date:  2018-02-01       Impact factor: 4.064

Review 7.  Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.

Authors:  Edward M Wolin
Journal:  Chest       Date:  2016-06-29       Impact factor: 9.410

Review 8.  Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.

Authors:  Dorian R A Swarts; Frans C S Ramaekers; Ernst-Jan M Speel
Journal:  Biochim Biophys Acta       Date:  2012-05-10

9.  Ki-67 Evaluation for Clinical Decision in Metastatic Lung Carcinoids: A Proof of Concept.

Authors:  Giuseppe Pelosi; Federica Massa; Gaia Gatti; Luisella Righi; Marco Volante; Nadia Birocco; Patrick Maisonneuve; Angelica Sonzogni; Sergio Harari; Adriana Albini; Mauro Papotti
Journal:  Clin Pathol       Date:  2019-02-19

10.  A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.

Authors:  Guido Rindi; David S Klimstra; Behnoush Abedi-Ardekani; Sylvia L Asa; Frederik T Bosman; Elisabeth Brambilla; Klaus J Busam; Ronald R de Krijger; Manfred Dietel; Adel K El-Naggar; Lynnette Fernandez-Cuesta; Günter Klöppel; W Glenn McCluggage; Holger Moch; Hiroko Ohgaki; Emad A Rakha; Nicholas S Reed; Brian A Rous; Hironobu Sasano; Aldo Scarpa; Jean-Yves Scoazec; William D Travis; Giovanni Tallini; Jacqueline Trouillas; J Han van Krieken; Ian A Cree
Journal:  Mod Pathol       Date:  2018-08-23       Impact factor: 7.842
View more
  2 in total

Review 1.  Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic Sites.

Authors:  Silvia Uccella; Stefano La Rosa; Jasna Metovic; Deborah Marchiori; Jean-Yves Scoazec; Marco Volante; Ozgur Mete; Mauro Papotti
Journal:  Endocr Pathol       Date:  2021-01-12       Impact factor: 3.943

2.  A molecular map of lung neuroendocrine neoplasms.

Authors:  Aurélie A G Gabriel; Emilie Mathian; Lise Mangiante; Catherine Voegele; Vincent Cahais; Akram Ghantous; James D McKay; Nicolas Alcala; Lynnette Fernandez-Cuesta; Matthieu Foll
Journal:  Gigascience       Date:  2020-10-30       Impact factor: 6.524
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.